APA (7th ed.) Citation

N, M., S, C. G., B, A. d. C., MI, G. R., M, C. C., P, G. V., . . . A, F. (2022). Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen. PloS one, 17(6), e0269399. https://doi.org/10.1371/journal.pone.0269399

Chicago Style (17th ed.) Citation

N, Martínez-Lago, et al. "Efficacy and Safety of FOLFIRI/aflibercept (FA) in an Elderly Population with Metastatic Colorectal Cancer (mCRC) After Failure of an Oxaliplatin-based Regimen." PloS One 17, no. 6 (2022): e0269399. https://doi.org/10.1371/journal.pone.0269399.

MLA (9th ed.) Citation

N, Martínez-Lago, et al. "Efficacy and Safety of FOLFIRI/aflibercept (FA) in an Elderly Population with Metastatic Colorectal Cancer (mCRC) After Failure of an Oxaliplatin-based Regimen." PloS One, vol. 17, no. 6, 2022, p. e0269399, https://doi.org/10.1371/journal.pone.0269399.